By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer announced that its board of directors has declared a quarterly dividend of $.07 per share.

The Waltham, Mass.-based firm said that the dividend is payable on Aug. 13 to all shareholders of record at the close of business on July 23.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.